Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 9,540 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: HEARTS Clear all

Conditions: Fibromyalgia Syndrome
Interventions: RSA Biofeedback, EEG Biofeedback Condition; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Coronary Arteriosclerosis, Acute Coronary Syndrome
Interventions: clopidogrel, placebo; Drug
Lead sponsor: Accumetrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 72
States / cities: Birmingham, Alabama • Scottsdale, Arizona • La Jolla, California + 59 more

Conditions: Surgery, Coronary Artery Disease
Interventions: Rocuronium, Neostigmine, Glycopyrrolate, Sugammadex; Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Heart Failure
Interventions: Finerenone, Empagliflozin; Drug
Lead sponsor: Colorado Prevention Center; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 46
States / cities: Fairhope, Alabama • Phoenix, Arizona • Chula Vista, California + 40 more

Conditions: Aortic Stenosis
Interventions: TAVR, Warfarin plus Aspirin, Aspirin Only; Device · Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: Not listed
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 7
States / cities: San Diego, California • Washington D.C., District of Columbia • Ridgewood, New Jersey + 4 more

Conditions: Hypercholesterolemia
Interventions: secoisolariciresinol diglucoside-containing extract of flaxseed; Dietary Supplement
Lead sponsor: Iowa State University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Ames, Iowa

Conditions: Mechanically Ventilated Patients, Extubation
Interventions: Not listed
Lead sponsor: Ottawa Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 7
States / cities: Ann Arbor, Michigan • Billings, Montana • Lebanon, New Hampshire + 4 more

Conditions: Pregnancy Abnormal
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Coronary Heart Disease, Depression
Interventions: Other; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Acute Kidney Injury
Interventions: QPI-1002, Placebo; Drug
Lead sponsor: Quark Pharmaceuticals; Industry
Eligibility: 45 Years and older
Enrollment: 341 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 20
States / cities: Tucson, Arizona • Gainesville, Florida • Jacksonville, Florida + 16 more

Conditions: Cardiovascular Disease
Interventions: Vitamin D3 + fish oil/fish oil placebo, Vitamin D3 placebo + fish oil/fish oil placebo; Dietary Supplement
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years and older
Enrollment: 1,025 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Univentricular Heart, Congenital Heart Disease, Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Interventions: iPSC-CL; Biological
Lead sponsor: HeartWorks, Inc.; Other
Eligibility: 18 Years to 40 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Smoking Cessation
Interventions: Intervention; Other
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 69 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Heart Transplant, Pediatric Heart Transplant, Rejection, Cardiac MRI, Cell Free DNA
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 6 Years to 25 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 22
States / cities: Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 16 more

Conditions: Heart Failure, Congestive
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Coronary Artery Disease
Interventions: ICR (Intensive Cardiac Rehabilitation), ICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating); Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease, Coronary Stenosis
Interventions: Comprehensive therapy program for risk factor modification; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 40 Years and older
Enrollment: 1,085 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Septic Shock
Interventions: Near-infrared spectroscopy assessment; Diagnostic Test
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiac Allograft Vasculopathy
Interventions: Macitentan; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer
Interventions: Reach Plus, Reach Plus Phone, Reach Plus Message; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 21 Years and older · Female only
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Cardiovascular Diseases, Vascular Disease, Arterial Occlusive Disease, Arteriosclerosis, Atherosclerosis
Interventions: Cypher Stent; Device
Lead sponsor: Cordis US Corp.; Industry
Eligibility: Not listed
Enrollment: 7,759 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Heart Transplant
Interventions: Prospera; Diagnostic Test
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 9
States / cities: Los Angeles, California • San Diego, California • Jacksonville, Florida + 6 more

Conditions: Heart Failure
Interventions: Neladenoson bialanate (BAY1067197), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 45 Years and older
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Chicago, Illinois • St Louis, Missouri • Lincoln, Nebraska + 1 more

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Barnes-Jewish Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

HRV Biofeedback in Fibromyalgia

GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety

Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

Flax Lignans and Heart Health

Weaning And Variability Evaluation

Spontaneous Fetal EEG Recording During Labor

Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862

A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

Impact of Vitamin D Supplementation on Cardiac Structure and Function

Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

Quit and Fit: A Tobacco Cessation and Energy Balance Pilot for African Americans

Non-invasive Prediction of EArly Cardiac rEjection

Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism

Impact of Time Restricted Eating on Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation

Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease

Near Infrared Spectroscopy (St02)

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors

An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

MIOX for Early Detection of Acute Kidney Injury After Cardiac Surgery